Abstract Objective To investigate the changes in the serum levels of oxidized phospholipids (OxPLs) and endothelial nitric oxide synthase (eNOS) and their association with coronary artery disease (CAL) in children in the acute stage of Kawasaki disease (KD), as well as the clinical significance of OxPLs and eNOS. Methods A prospective study was conducted on 95 children in the acute stage of KD (KD group). According to the presence of absence of CAL, the KD group was further divided into a CAL subgroup and a non-CAL (NCAL) subgroup. Thirty children with fever due to lower respiratory tract infection were enrolled as the fever group. Thirty healthy children who underwent physical examination were enrolled as the healthy control group. The above groups were compared in terms of general information and serum levels of OxPLs, eNOS and other laboratory indexes, and the correlation between OxPLs level and eNOS level was analyzed. Results The KD group had a significantly higher level of OxPLs and a significantly lower level of eNOS compared with the fever group and the healthy control group (P<0.05). After treatment, the children with KD had a significantly decreased OxPLs level and a significantly increased eNOS level (P<0.05). Compared with the NCAL subgroup, the CAL subgroup had a significantly higher level of OxPLs and a significantly lower level of eNOS (P<0.05). Among the children of KD, the level of OxPLs was negatively correlated with that of eNOS (rs=-0.353, P<0.05). Conclusions Serum OxPLs and eNOS in the acute stage of KD may be involved in the development of CAL in children with KD, and therefore, they may be used as the biomarkers to predict CAL in these children.
Corresponding Authors:
He X-H，E-mail：He_xh101@163.com
E-mail: He_xh101@163.com
Cite this article:
ZHU Liu-Rong,HE Xue-Hua,YUAN Yong-Hua et al. Changes and significance of oxidized phospholipids and endothelial nitric oxide synthase in the acute stage of Kawasaki disease[J]. CJCP, 2024, 26(8): 829-834.
ZHU Liu-Rong,HE Xue-Hua,YUAN Yong-Hua et al. Changes and significance of oxidized phospholipids and endothelial nitric oxide synthase in the acute stage of Kawasaki disease[J]. CJCP, 2024, 26(8): 829-834.
F?rstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis[J]. Circ Res, 2017, 120(4): 713-735. PMID: 28209797. DOI: 10.1161/CIRCRESAHA.116.309326.
Dunn S, Vohra RS, Murphy JE, et al. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease[J]. Biochem J, 2008, 409(2): 349-355. PMID: 18092947. DOI: 10.1042/BJ20071196.
Tsimikas S, Mallat Z, Talmud PJ, et al. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events[J]. J Am Coll Cardiol, 2010, 56(12): 946-955. PMID: 20828647. DOI: 10.1016/j.jacc.2010.04.048.
Yu X, Hirono K I, Ichida F, et al. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease[J]. Pediatr Res, 2004, 55(4): 688-694. PMID: 14764920. DOI: 10.1203/01.PDR.0000113464.93042.A4.
Borzutzky A, Gutiérrez M, Talesnik E, et al. High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease[J]. Clin Rheumatol, 2008, 27(7): 845-850. PMID: 18071779. DOI: 10.1007/s10067-007-0808-6.
Nakashima Y, Sakai Y, Mizuno Y, et al. Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease[J]. Cardiovasc Res, 2021, 117(1): 96-108. PMID: 31782770. DOI: 10.1093/cvr/cvz305.
Wu F, Wilson JX. Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction[J]. Cardiovasc Res, 2009, 81(1): 38-45. PMID: 18791203. PMCID: PMC2605194. DOI: 10.1093/cvr/cvn246.
uczak A, Madej M, Kasprzyk A, et al. Role of the eNOS uncoupling and the nitric oxide metabolic pathway in the pathogenesis of autoimmune rheumatic diseases[J]. Oxid Med Cell Longev, 2020, 2020: 1417981. PMID: 32351667. PMCID: PMC7174952. DOI: 10.1155/2020/1417981.
Gharavi NM, Baker NA, Mouillesseaux KP, et al. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids[J]. Circ Res, 2006, 98(6): 768-776. PMID: 16497987. DOI: 10.1161/01.RES.0000215343.89308.93.
Gradinaru D, Borsa C, Ionescu C, et al. Oxidized LDL and NO synthesis: biomarkers of endothelial dysfunction and ageing[J]. Mech Ageing Dev, 2015, 151: 101-113. PMID: 25804383. DOI: 10.1016/j.mad.2015.03.003.
Chen WH, Chen CH, Hsu MC, et al. Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: interlocking biology between eNOS activity and L-arginine metabolism[J]. Biomed Pharmacother, 2024, 171: 116192. PMID: 38262153. DOI: 10.1016/j.biopha.2024.116192.
Philippova M, Resink T, Erne P, et al. Oxidised phospholipids as biomarkers in human disease[J]. Swiss Med Wkly, 2014, 144: w14037. PMID: 25539162. DOI: 10.4414/smw.2014.14037.
